These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 4352743

  • 1. Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.
    Chayoth R, Epstein SM, Field JB.
    Cancer Res; 1973 Aug; 33(8):1970-4. PubMed ID: 4352743
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA, Thompson WJ, Strada SJ, Couture-Murillo B, Morris HP, Robison GA.
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract] [Full Text] [Related]

  • 3. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
    DeRubertis FR, Craven P.
    Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
    DeRubertis FR, Craven PA.
    Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
    [Abstract] [Full Text] [Related]

  • 10. Effect of prostaglandins on adenylate cyclase activities in membranes from liver and transplantable hepatomas.
    Pradhan TK, Criss WE.
    Cancer Biochem Biophys; 1976 Aug; 1(5):239-43. PubMed ID: 184916
    [Abstract] [Full Text] [Related]

  • 11. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine.
    Craven PA, Derubertis FR.
    Biochim Biophys Acta; 1977 Apr 27; 497(2):415-27. PubMed ID: 192313
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of enzymes by glucagon, glucose repression, adenosine 3',5'-monophosphate concentration during carcinogenesis and in Morris 6918A hepatoma.
    Sudilovsky O, Gunter R.
    Cancer Res; 1975 Apr 27; 35(4):1069-74. PubMed ID: 234792
    [Abstract] [Full Text] [Related]

  • 14. Independence of pituitary tumor-mediated suppression of growth hormone secretion and cyclic 3',5'-adenosine monophosphate production.
    MacLeod RM, Lehmeyer JE.
    Cancer Res; 1973 Apr 27; 33(4):843-8. PubMed ID: 4348775
    [No Abstract] [Full Text] [Related]

  • 15. Cyclic 3',5'-nucleotide monophosphate phosphodiesterase activity in hepatomas of different growth rates.
    Rhoads AR, Morris HP, West WL.
    Cancer Res; 1972 Dec 27; 32(12):2651-5. PubMed ID: 4345399
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver.
    Mayer SE.
    J Pharmacol Exp Ther; 1972 Apr 27; 181(1):116-25. PubMed ID: 4335168
    [No Abstract] [Full Text] [Related]

  • 18. [Cyclic AMP - its importance for clinical medicine].
    Schwarzmeier JD.
    Subsid Med; 1975 Apr 27; 1-2():21-7. PubMed ID: 163557
    [No Abstract] [Full Text] [Related]

  • 19. Anomalous adenosine cyclic 3':5'-monophosphate responses to glucagon in patients with hepatocellular carcinoma.
    Pun KK, Ho PW, Yeung RT.
    Cancer Res; 1986 Apr 27; 46(4 Pt 2):2152-4. PubMed ID: 3004721
    [Abstract] [Full Text] [Related]

  • 20. Functional and structural alterations of liver ergastoplasmic membranes during DL-ethionine hepatocarcinogenesis.
    Gravela E, Feo F, Canuto RA, Garcea R, Gabriel L.
    Cancer Res; 1975 Nov 27; 35(11 Pt 1):3041-7. PubMed ID: 241483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.